<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2017-23-2-103-111</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-584</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>ГЕНЕТИЧЕСКИЙ ПОЛИМОРФИЗМ ГЕНОВ ЦИТОКИНОВ СИСТЕМЫ ВОСПАЛЕНИЯ И СОСТОЯНИЕ СОСУДИСТОЙ СТЕНКИ У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>GENETIC POLYMORPHISM OF THE INFLAMMATORY CYTOKINE GENES AND ARTERIAL WALL PROPERTIES IN HYPERTENSIVE PATIENTS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минушкина</surname><given-names>Л. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Minushkina</surname><given-names>L. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии</p></bio><bio xml:lang="en"><p>MD, PhD, DSc, Professor</p></bio><email xlink:type="simple">minushkina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асейчева</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Aseycheva</surname><given-names>O. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии</p></bio><bio xml:lang="en"><p>MD, Assistant</p></bio><email xlink:type="simple">minushkina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кочкина</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kochkina</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии</p></bio><bio xml:lang="en"><p>MD, Assistant</p></bio><email xlink:type="simple">minushkina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитин</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitin</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий лабораторией</p></bio><bio xml:lang="en"><p>MD, Head, Laboratory</p></bio><email xlink:type="simple">minushkina@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Затейщиков</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zateyshchikov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры терапии, кардиологии и функциональной диагностики с курсом нефрологии ФГБУ ДПО ЦГМА УД ПРФ, руководитель первичного сосудистого отделения государственного бюджетного учреждения здравоохранения «Городская клиническая больница № 51 Департамента здравоохранения города Москвы», научный сотрудник ФГБУ ФНКЦ СВКП МТ ФМБА России</p></bio><bio xml:lang="en"><p>MD, PhD, DSc, Professor, Central State Medical Academy of Department of Presidential Affairs, Head, Angiology Department, City Clinical Hospital № 51, Researcher, Federal Scientific Clinical Center of Specialized Methods Medical Care and Medical Technology</p></bio><email xlink:type="simple">minushkina@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение дополнительного профессионального образования «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of Department of Presidential Affairs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Федеральный научно-клинический центр специализированных видов клинической помощи и медицинских технологий» Федерального медико-биологического агентства&#13;
России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Clinical Center of Specialized Methods Medical Care and Medical Technology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение дополнительного профессионального образования «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации&#13;
Государственное бюджетное учреждение здравоохранения «Городская клиническая больница № 51 Департамента здравоохранения города Москвы»&#13;
Федеральное государственное бюджетное учреждение «Федеральный научно-клинический центр специализированных видов клинической помощи и медицинских технологий» Федерального медико-биологического агентства&#13;
России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of Department of Presidential Affairs&#13;
City Clinical Hospital № 51, Moscow&#13;
Federal Scientific Clinical Center of Specialized Methods Medical Care and Medical Technology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>15</day><month>05</month><year>2017</year></pub-date><volume>23</volume><issue>2</issue><fpage>103</fpage><lpage>111</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Минушкина Л.О., Асейчева О.Ю., Кочкина М.С., Никитин А.Г., Затейщиков Д.А., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Минушкина Л.О., Асейчева О.Ю., Кочкина М.С., Никитин А.Г., Затейщиков Д.А.</copyright-holder><copyright-holder xml:lang="en">Minushkina L.O., Aseycheva O.Y., Kochkina M.S., Nikitin A.G., Zateyshchikov D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/584">https://htn.almazovcentre.ru/jour/article/view/584</self-uri><abstract><p>Цель исследования — изучить ассоциацию полиморфных маркеров генов С‑реактивного белка (CRP), интерлейкина 10 (IL10), интерлейкина 6 (IL6), лимфотоксина альфа (LTA) и фактора некроза опухоли (TNFА) с изменениями артериальной ригидности у больных артериальной гипертензией (АГ). Материалы и методы. Обследовано 130 больных с АГ (64 (49,3%) мужчин и 66 (50,7%) женщин), средний возраст 63,7 ± 12,87 года. Толщину комплекса интима-медиа измеряли по методике, предложенной P. Pignolli. Жесткость артерий оценивалась посредством измерения скорости пульсовой волны (СПВ) на сегменте сонная–бедренная и сонная–лучевая артерии. Центральное пульсовое давление (ПД) в аорте рассчитывалось с использованием контурного анализа пульсовой кривой. Результаты. Ассоциации полиморфных маркеров A (-3872)G, G (-2667)C, A (-5237)G гена CRP, G (-1082)A гена IL10, C (-174) G гена IL6, и A (-308)G гена TNFA со скоростью распространения пульсовой волны, ПД в аорте, наличием атеросклеротических бляшек сонных артерий выявлено не было. В группе больных с ПД в аорте больше 50 мм рт. ст. доля носителей генотипа AA полиморфного маркера C804A гена LTA была больше (р = 0,037). У носителей генотипа AA СПВ на сегменте сонная–бедренная артерия оказалась существенно выше по сравнению с носителями генотипа СС (13,4 и 11,9 м/с, р = 0,042), а также у них было более высокое ПД в аорте. Также более высокие показатели ПД в аорте и СПВ были выявлены у носителей генотипа GG полиморфного маркера A (252)G гена LTA. Среди больных с наличием атеросклеротических бляшек сонных артерий было больше носителей генотипа AA полиморфного маркера G (-3014)A гена CRP (р = 0,031). Выводы. Показано, что полиморфизм гена CRP ассоциирован с развитием каротидного атеросклероза и увеличением центрального ПД, а полиморфизм гена лимфотоксина альфа — с увеличением ригидности аорты и крупных артерий у больных АГ высокого риска. Эти данные подтверждают положение о вовлеченности провоспалительных цитокинов в процессы развития атеросклероза и формирования эндотелиальной дисфункции.</p><p> </p></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To elucidate the association between polymorphic markers of the genes of C-reactive protein (CRP), interleukin 10 (IL10), interleukin 6 (IL6), lymphotoxin alpha (LTA) and tumor necrosis factor (TNFA) and changes of arterial stiffness in hypertensive patients. Design and methods. The study included 130 patients with hypertension (HTN) (64 (49,3%) men and 66 (50,7%) women), average age 63,7 ± 12,87 years. The intima-media thickness was measured by the method proposed by P. Pignolli. The arterial stiffness was assessed by the carotidfemoral and carotid-radial pulse wave velocity (PWV). Central aortic pulse pressure (PP) was calculated using pulse contour analysis. Results. An association of polymorphic markers of A (-3872)G, G (-2667)C, A (-5237) G CRP gene, G (-1082)A gene IL10, C (-174)G gene IL6, and A (-308)G gene TNFA with pulse wave velocity, PP in the aorta, the presence of atherosclerotic plaques of carotid arteries was found. Among patients with aortic PP &gt; 50 mmHg the frequency of AA genotype carriers of polymorphic marker C804A LTA gene was higher (p = 0,037). Carriers AA genotype had a significantly greater carotid-femoral PWV as compared with native CC genotype (13,4 and 11,9 m/s, p = 0,042) and higher PP in the aorta. Also, higher PP and aortic PWV were found in carriers of GG genotype of A (252)G LTA gene. Among patients with the presence of atherosclerotic plaques of carotid arteries the frequency of AA genotype of the G (-3014)A CRP gene was higher (p = 0,031). Conclusion. Thus, we have shown that CRP gene polymorphism is associated with the development of carotid atherosclerosis and increased central PP, while lymphotoxin alpha gene polymorphism is associated with the increase in arterial stiffness in high risk hypertensive patients. Our data confirm the involvement of pro-inflammatory cytokines in the development of atherosclerosis and endothelial dysfunction.</p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>генетический полиморфизм</kwd><kwd>воспаление</kwd><kwd>сосудистая ригидность</kwd><kwd>ген С‑реактивного белка</kwd><kwd>ген лимфотоксина альфа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertension</kwd><kwd>genetic polymorphism</kwd><kwd>inflammation</kwd><kwd>arterial stiffness</kwd><kwd>C‑reactive protein gene</kwd><kwd>lymphotoxin-alpha gene</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kusche-Vihrog K, Urbanova K, Blanqué A, Wilhelmi M, Schillers H, Kliche K et al. C-reactive protein makes human endothelium stiff and tight. Hypertension. 2011;57(2):231–7.</mixed-citation><mixed-citation xml:lang="en">Kusche-Vihrog K, Urbanova K, Blanqué A, Wilhelmi M, Schillers H, Kliche K et al. C-reactive protein makes human endothelium stiff and tight. Hypertension. 2011;57(2):231–7.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Babbitt DM, Kim JS, Forrester SJ, Brown MD, Park JY. Effect of Interleukin-10 and laminar shear stress on endothelial nitric oxide synthase and nitric oxide in African American human umbilical vein endothelial cells. Ethn Dis. 2015;25(4):413–8. doi: 10. 18865/ed.25.4.413. PubMed PMID: 26674844; PubMed Central PMCID: PMC4671427</mixed-citation><mixed-citation xml:lang="en">Babbitt DM, Kim JS, Forrester SJ, Brown MD, Park JY. Effect of Interleukin-10 and laminar shear stress on endothelial nitric oxide synthase and nitric oxide in African American human umbilical vein endothelial cells. Ethn Dis. 2015;25(4):413–8. doi: 10. 18865/ed.25.4.413. PubMed PMID: 26674844; PubMed Central PMCID: PMC4671427</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399–406.</mixed-citation><mixed-citation xml:lang="en">Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399–406.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Минушкина Л. О., Чумакова О. С., Селезнева Н. Д., Евдокимова М. А., Осмоловская В. С., Благодатских К. А. и др. Развитие гипертрофии левого желудочка, ассоциированное с генетическим полиморфизмом медиаторов системы воспаления. Российский кардиологический журнал. 2014;10(114):23–28. [Minushkina LO, Chumakova OS, Selezneva ND, Evdokimova MA, Osmolovskaya VS, Blagodatskikh KA et al. Left ventricular hypertrophy development, associated with genetic polymorphism of inﬂammatory mediators. Russian Journal of Cardiology. 2014;10 (114):23–28. In Russian].</mixed-citation><mixed-citation xml:lang="en">Минушкина Л. О., Чумакова О. С., Селезнева Н. Д., Евдокимова М. А., Осмоловская В. С., Благодатских К. А. и др. Развитие гипертрофии левого желудочка, ассоциированное с генетическим полиморфизмом медиаторов системы воспаления. Российский кардиологический журнал. 2014;10(114):23–28. [Minushkina LO, Chumakova OS, Selezneva ND, Evdokimova MA, Osmolovskaya VS, Blagodatskikh KA et al. Left ventricular hypertrophy development, associated with genetic polymorphism of inﬂammatory mediators. Russian Journal of Cardiology. 2014;10 (114):23–28. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Suna S, Sakata Y, Sato H, Mizuno H, Nakatani D, Shimizu M et al. Up-regulation of cell adhesion molecule genes in human endothelial cells stimulated by lymphotoxin alpha: DNA microarray analysis. J Atheroscler Thromb. 2008;15(3):160–5.</mixed-citation><mixed-citation xml:lang="en">Suna S, Sakata Y, Sato H, Mizuno H, Nakatani D, Shimizu M et al. Up-regulation of cell adhesion molecule genes in human endothelial cells stimulated by lymphotoxin alpha: DNA microarray analysis. J Atheroscler Thromb. 2008;15(3):160–5.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-alpha N26(804A) allele with coronary artery disease. Eur J Hum Genet. 2004;12(9):770–4.</mixed-citation><mixed-citation xml:lang="en">PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-alpha N26(804A) allele with coronary artery disease. Eur J Hum Genet. 2004;12(9):770–4.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nakayama T, Soma M, Sato N, Haketa A, Kosuge K, Aoi N et al. An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene. Am J Hypertens. 2004;17(11 Pt 1):1045–9.</mixed-citation><mixed-citation xml:lang="en">Nakayama T, Soma M, Sato N, Haketa A, Kosuge K, Aoi N et al. An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene. Am J Hypertens. 2004;17(11 Pt 1):1045–9.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ikeda S, Tanaka N, Arai T, Chida K, Muramatsu M, Sawabe M. Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Atherosclerosis. 2012;221(2):458–60.</mixed-citation><mixed-citation xml:lang="en">Ikeda S, Tanaka N, Arai T, Chida K, Muramatsu M, Sawabe M. Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Atherosclerosis. 2012;221(2):458–60.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki G, Izumi S, Hakoda M, Takahashi N. LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis. 2004;176(1):91–4.</mixed-citation><mixed-citation xml:lang="en">Suzuki G, Izumi S, Hakoda M, Takahashi N. LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis. 2004;176(1):91–4.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K et al. Stroke SNP Consortium. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke. 2009;40(3):683–95.</mixed-citation><mixed-citation xml:lang="en">Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K et al. Stroke SNP Consortium. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke. 2009;40(3):683–95.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yamasaki Y, Katakami N, Sakamoto K, Kaneto H, Matsuhisa M, Sato H et al. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care. 2006;29 (11):2445–51.</mixed-citation><mixed-citation xml:lang="en">Yamasaki Y, Katakami N, Sakamoto K, Kaneto H, Matsuhisa M, Sato H et al. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care. 2006;29 (11):2445–51.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar P, Kumar A, Misra S, Faruq M, Vivekanandhan S, Srivastava AK et al. Association between lymphotoxin alpha (-252 A/G and –804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study. Int J Neurosci. 2016; 126(12):1127–35. doi:10.3109/ 00207454.2015.1134527.</mixed-citation><mixed-citation xml:lang="en">Kumar P, Kumar A, Misra S, Faruq M, Vivekanandhan S, Srivastava AK et al. Association between lymphotoxin alpha (-252 A/G and –804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study. Int J Neurosci. 2016; 126(12):1127–35. doi:10.3109/ 00207454.2015.1134527.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lachmeijer AM, Crusius JB, Pals G, Dekker GA, Arngrímsson R, ten Kate LP. Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia. Obstet Gynecol. 2001;98(4):612–9.</mixed-citation><mixed-citation xml:lang="en">Lachmeijer AM, Crusius JB, Pals G, Dekker GA, Arngrímsson R, ten Kate LP. Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia. Obstet Gynecol. 2001;98(4):612–9.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension. 2009;53(2):150–7. doi:10.1161/HYPER-TENSIONAHA.108.117622. Epub 2008 Dec 15.</mixed-citation><mixed-citation xml:lang="en">Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension. 2009;53(2):150–7. doi:10.1161/HYPER-TENSIONAHA.108.117622. Epub 2008 Dec 15.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Благодатских К. А., Никитин А. Г., Пушков А. А., Благо- датских Е. Г., Осмоловская В. С., Асейчева О. Ю. и др. Полиморфные маркеры G2667C, G3014A, C3872T, A5237G гена CRP и генетическая предрасположенность к неблагоприятному течению ишемической болезни сердца у больных, перенесших обострение ишемической болезни сердца. Медицинская генетика. 2011;4:3–9. [Blagodatskikh KA, Nikitin AG, Pushkov AA, Blagodatskikh EG, Osmolovkaya VS, Aseicheva OYu et al. Polymorphic markers G2667C, G3014A, C3872T, A5237G of CRP gene and genetic association with unfavorable outcomes of coronary artery disease in patients with history of acute ischemic heart disease. Medical Genetics. 2011;4:3–9. In Russian].</mixed-citation><mixed-citation xml:lang="en">Благодатских К. А., Никитин А. Г., Пушков А. А., Благо- датских Е. Г., Осмоловская В. С., Асейчева О. Ю. и др. Полиморфные маркеры G2667C, G3014A, C3872T, A5237G гена CRP и генетическая предрасположенность к неблагоприятному течению ишемической болезни сердца у больных, перенесших обострение ишемической болезни сердца. Медицинская генетика. 2011;4:3–9. [Blagodatskikh KA, Nikitin AG, Pushkov AA, Blagodatskikh EG, Osmolovkaya VS, Aseicheva OYu et al. Polymorphic markers G2667C, G3014A, C3872T, A5237G of CRP gene and genetic association with unfavorable outcomes of coronary artery disease in patients with history of acute ischemic heart disease. Medical Genetics. 2011;4:3–9. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop I, Baños-González MA, Torres-Hernández ME, López-Narváez ML et al. The role of gene variants of the inﬂammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(8):11958–84.</mixed-citation><mixed-citation xml:lang="en">Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop I, Baños-González MA, Torres-Hernández ME, López-Narváez ML et al. The role of gene variants of the inﬂammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(8):11958–84.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Li CS, Guo BR, Guo Z, Yang J, Zheng HF, Wang AL. Association between C-reactive protein gene +1059 G/C poly-morphism and the risk of coronary heart disease: a meta-analysis. Chin Med J (Engl). 2013;126(24):4780–5.</mixed-citation><mixed-citation xml:lang="en">Li CS, Guo BR, Guo Z, Yang J, Zheng HF, Wang AL. Association between C-reactive protein gene +1059 G/C poly-morphism and the risk of coronary heart disease: a meta-analysis. Chin Med J (Engl). 2013;126(24):4780–5.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">González-Giraldo Y, Barreto GE, Fava C, Forero DA. Ischemic stroke and six genetic variants in CRP, EPHX2, FGA, and NOTCH3 genes: a meta-analysis. J Stroke Cerebrovasc Dis. 2016;25 (9):2284–2289. pii: S1052–3057 (16)30091-X. doi:10.1016/j.jstro kecerebrovasdis.2016.05.020.</mixed-citation><mixed-citation xml:lang="en">González-Giraldo Y, Barreto GE, Fava C, Forero DA. Ischemic stroke and six genetic variants in CRP, EPHX2, FGA, and NOTCH3 genes: a meta-analysis. J Stroke Cerebrovasc Dis. 2016;25 (9):2284–2289. pii: S1052–3057 (16)30091-X. doi:10.1016/j.jstro kecerebrovasdis.2016.05.020.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kuhlenbaeumer G, Huge A, Berger K, Kessler C, Voelzke H, Funke H et al. Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke. Cerebrovasc Dis. 2010;30(5):476–82. doi:10.1159/000319021.</mixed-citation><mixed-citation xml:lang="en">Kuhlenbaeumer G, Huge A, Berger K, Kessler C, Voelzke H, Funke H et al. Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke. Cerebrovasc Dis. 2010;30(5):476–82. doi:10.1159/000319021.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Liu ZZ, Ding XR, Zheng HG, Zhang G, Wang RM, Kang XX. Study on the association of the CRP gene +1444C/T polymorphism with symptomatic carotid artery stenosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009;26(4):435–8.</mixed-citation><mixed-citation xml:lang="en">Liu ZZ, Ding XR, Zheng HG, Zhang G, Wang RM, Kang XX. Study on the association of the CRP gene +1444C/T polymorphism with symptomatic carotid artery stenosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009;26(4):435–8.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jylhävä J, Eklund C, Pessi T, Raitakari OT, Juonala M, Kähönen M et al. Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the cardiovascular risk in young ﬁns study. Clin Exp Immunol. 2009;155(1):53–8. doi:10.1111/j.1365–2249.2008.03752</mixed-citation><mixed-citation xml:lang="en">Jylhävä J, Eklund C, Pessi T, Raitakari OT, Juonala M, Kähönen M et al. Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the cardiovascular risk in young ﬁns study. Clin Exp Immunol. 2009;155(1):53–8. doi:10.1111/j.1365–2249.2008.03752</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocr Metab. 2003;88(3):1055–1058.</mixed-citation><mixed-citation xml:lang="en">Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocr Metab. 2003;88(3):1055–1058.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sbarsi I, Falcone C, Boiocchi C, Campo I, Zorzetto M, De Silvestri A et al. Inﬂammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol. 2007;20(1):145–54.</mixed-citation><mixed-citation xml:lang="en">Sbarsi I, Falcone C, Boiocchi C, Campo I, Zorzetto M, De Silvestri A et al. Inﬂammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol. 2007;20(1):145–54.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
